AngioDynamics tumbles after lower 2023 results guidance

AngioDynamics

30/03/2023 13:52

** Shares of medical technology company AngioDynamics Inc
 ANGO.O  down 16.8% at $10.38 premarket
    ** Now expects 2023 net sales between $338 mln and $342 mln
guidance, decrease from prior guidance of $342 mln to $348 mln
    ** Lowers 2023 adjusted loss per share guidance in the range
of $0.06 to $0.01, from prior guidance of earnings of $0.01 to
$0.06
    ** Company reports Q3 adjusted loss per share of $0.03,
compared to Wall Street estimate of $0.01
    ** As of Feb 28, ANGO has $30.1 mln in cash and
cash-equivalents
    ** Shares down 9.44% YTD

 (Reporting by Tanya Jain)
 ((Tanya.Jain@thomsonreuters.com))